Insider · CIK 0001408593

Pavliv Leo

Reports to the SEC for 1 company · NASHVILLE, TN

sec.gov

Transactions

Companies

Filings

CIK

0001408593

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-31	CPIXCUMBERLAND PHARMACEUTICALS INCJ Other	SVP and Chief Development Off.	JOther	−33.5K sh	$2.09	−$70K	129,618
2022-03-16	CPIXCUMBERLAND PHARMACEUTICALS INC · Options (right to buy)D Disposition to Issuer	SVP and Chief Development Off.	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-16	CPIXCUMBERLAND PHARMACEUTICALS INC · Options (right to buy)A Award	SVP and Chief Development Off.	AAward	+5,000 sh	—	—	5,000
2021-03-17	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−2,870 sh	$3.22	−$9,241.4	168,118
2021-03-17	CPIXCUMBERLAND PHARMACEUTICALS INC · Options (right to buy)A Award	SVP and Chief Development Off.	AAward	+5,000 sh	—	—	5,000
2021-03-17	CPIXCUMBERLAND PHARMACEUTICALS INC · Options (right to buy)D Disposition to Issuer	SVP and Chief Development Off.	DDisposition to Issuer	−5,000 sh	—	—	0
2020-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+25K sh	$3.56	+$89K	165,988
2020-03-18	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−9,637 sh	$3.53	−$34K	140,988
2019-11-26	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−3,710 sh	$4.93	−$18.3K	154,051
2019-08-26	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−1,850 sh	$5.63	−$10.4K	157,761
2019-05-21	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−1,850 sh	$6.30	−$11.7K	159,611
2019-03-22	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+25K sh	$5.98	+$150K	163,804
2019-03-22	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−2,343 sh	$5.62	−$13.2K	161,461
2018-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+25K sh	$6.70	+$168K	132,861
2018-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−2,557 sh	$6.70	−$17.1K	130,304
2017-04-07	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+10K sh	$6.45	+$64.5K	111,443
2017-04-07	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−3,582 sh	$6.45	−$23.1K	107,861
2016-05-26	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−7,296 sh	$4.51	−$32.9K	101,443
2016-04-06	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+5,000 sh	$4.34	+$21.7K	112,590
2016-04-06	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−3,851 sh	$4.34	−$16.7K	108,739
2015-12-02	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+6,500 sh	$5.58	+$36.3K	107,590
2015-03-27	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+5,000 sh	$6.86	+$34.3K	102,695
2015-03-27	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−1,605 sh	$6.88	−$11K	101,090
2014-03-21	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+5,000 sh	$4.58	+$22.9K	97,695
2013-03-26	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	−10K sh	$4.78	−$47.8K	92,695
2013-03-18	CPIXCUMBERLAND PHARMACEUTICALS INCM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	+160K sh	$3.50	+$560K	225,395
2013-03-18	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−133K sh	$4.78	−$634K	92,695
2013-03-18	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	−160K sh	—	—	0
2012-05-22	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsD Disposition to Issuer	SVP and Chief Development Off.	DDisposition to Issuer	−10K sh	—	—	0
2012-05-22	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsD Disposition to Issuer	SVP and Chief Development Off.	DDisposition to Issuer	−9,000 sh	—	—	0
2012-05-22	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsD Disposition to Issuer	SVP and Chief Development Off.	DDisposition to Issuer	−12K sh	—	—	0
2012-05-22	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsD Disposition to Issuer	SVP and Chief Development Off.	DDisposition to Issuer	−12K sh	—	—	0
2012-05-22	CPIXCUMBERLAND PHARMACEUTICALS INC · Restricted stockA Award	SVP and Chief Development Off.	AAward	+19K sh	$6.41	+$121K	18,950
2012-03-16	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+10K sh	$7.72	+$77.2K	36,445
2011-08-17	CPIXCUMBERLAND PHARMACEUTICALS INCM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	+3,000 sh	$1.63	+$4,890	28,145
2011-08-17	CPIXCUMBERLAND PHARMACEUTICALS INCS Sale	SVP and Chief Development Off.	SSale	−1,700 sh	$5.91	−$10K	26,445
2011-08-17	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	−3,000 sh	—	—	0
2011-03-24	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	SVP and Chief Development Off.	AAward	+5,000 sh	—	—	25,145
2010-05-25	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	SVP and Chief Development Off.	PPurchase	+5,000 sh	$6.78	+$33.9K	20,145
2010-05-18	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−6,289 sh	$7.12	−$44.8K	15,145
2010-05-15	CPIXCUMBERLAND PHARMACEUTICALS INCM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	+18K sh	$0.93	+$16.7K	21,434
2010-05-15	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	−18K sh	—	—	0
2010-03-26	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsA Award	SVP and Chief Development Off.	AAward	+12K sh	—	—	12,000
2009-12-25	CPIXCUMBERLAND PHARMACEUTICALS INCM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	+5,000 sh	$0.50	+$2,500	5,000
2009-12-25	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	SVP and Chief Development Off.	FTax Payment	−1,566 sh	$14.14	−$22.1K	3,434
2009-12-25	CPIXCUMBERLAND PHARMACEUTICALS INC · OptionsM Exercise/Conversion	SVP and Chief Development Off.	MExercise/Conversion	−5,000 sh	—	—	0

Recent filings

Accepted (ET)
Jul 14
Pavliv Leo0001209191-22-040113
SEC(opens sec.gov)
Apr 294
Pavliv Leo0001209191-22-026150
SEC(opens sec.gov)
Jun 114
Pavliv Leo0001209191-21-039925
SEC(opens sec.gov)
Apr 174
Pavliv Leo0001209191-20-024873
SEC(opens sec.gov)
Nov 294
Pavliv Leo0001209191-19-058440
SEC(opens sec.gov)
Aug 304
Pavliv Leo0001209191-19-047852
SEC(opens sec.gov)
May 314
Pavliv Leo0001209191-19-033697
SEC(opens sec.gov)
Mar 224
Pavliv Leo0001209191-19-021049
SEC(opens sec.gov)
Mar 234
Pavliv Leo0001209191-18-021483
SEC(opens sec.gov)
Apr 74
CUMBERLAND PHARMACEUTICALS INC0001209191-17-026299
SEC(opens sec.gov)
May 274
CUMBERLAND PHARMACEUTICALS INC0001209191-16-124141
SEC(opens sec.gov)
Apr 84
CUMBERLAND PHARMACEUTICALS INC0001209191-16-113796
SEC(opens sec.gov)

Companies

CUMBERLAND PHARMACEUTICALS INCSVP and Chief Development Off.CPIX

Address

2525 WEST END AVE. SUITE 950

NASHVILLE, TN, 37203